Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
The cultural mouse
2001 StandoutNobel
A Mutation of Angiotensinogen in a Patient with Preeclampsia Leads to Altered Kinetics of the Renin-Angiotensin System
1995
Genetic Control of Fertility and Embryonic Waste in the Mouse: A Rolefor Angiotensinogen1
2000
Preeclampsia: What we know and what we do not know
2000
Recent Insights into the Pathogenesis of Pre-eclampsia
2002
Many little things: one geneticist's view of complex diseases
2005 StandoutNobel
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
The MEME Suite
2015 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Pathogenesis and genetics of pre-eclampsia
2001
Etiology and pathogenesis of preeclampsia: Current concepts
1998
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Susceptibility Loci for Preeclampsia on Chromosomes 2p25 and 9p13 in Finnish Families
2003
Genetic variants in pre-eclampsia: a meta-analysis
2013
U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM
1995 StandoutNobel
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Pre-eclampsia
2005 Standout
Forty years with homologous recombination
2001 StandoutNobel
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Haplotypes of Angiotensinogen in Essential Hypertension
1997
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
1997
CYP3A Variation and the Evolution of Salt-Sensitivity Variants
2004
Pre-eclampsia
2010 Standout
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor
1999
Molecular and Genetic Aspects of Preeclampsia: State of the Art
2000
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Paternal and Maternal Components of the Predisposition to Preeclampsia
2001
What do dysfunctional serpins tell us about molecular mobility and disease?
1995
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Renin Cells Are Precursors for Multiple Cell Types that Switch to the Renin Phenotype When Homeostasis Is Threatened
2004 StandoutNobel
The genetics of pre‐eclampsia: a feto‐placental or maternal problem?
2003
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Genes and the preeclampsia syndrome
2008
Preeclampsia prevention and management
2000
Pre-eclampsia
2015 Standout
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Functional expression of the human angiotensinogen gene in transgenic mice.
1994
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice
1999
Serpin Structure, Mechanism, and Function
2002 Standout
Preeclampsia Prevention and Management
2000
Homeostatic Responses in the Adrenal Cortex to the Absence of Aldosterone in Mice
2005 StandoutNobel
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
2005 StandoutNobel
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
AT 1 Receptor Agonistic Antibodies From Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor
2000
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Seven Lessons From Two Candidate Genes in Human Essential Hypertension
1999
Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat
1995
Angiotensin-converting enzyme and male fertility
1998 StandoutNobel
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
High incidence of XXY and XYY males among the offspring of female chimeras from embryonic stem cells.
1995 StandoutNobel
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
Genetic control of blood pressure and the angiotensinogen locus.
1995 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics
2003
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Uncompensated polyuria in a mouse model of Bartter's syndrome
2000 StandoutNobel
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development
2003 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
1996 StandoutNobel
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
M235T angiotensinogen gene polymorphism and cardiovascular renal risk
1999
Works of S. Tomoda being referenced
A molecular variant of angiotensinogen associated with preeclampsia
1993
Prediction of Pregnancy‐Induced Hypertension by Isometric Exercise
1994